Chantal Tasset - Galapagos Head Devel

GLPG Stock  EUR 23.96  0.98  3.93%   

Insider

Chantal Tasset is Head Devel of Galapagos NV
Phone32 1 534 29 00
Webhttps://www.glpg.com

Galapagos Management Efficiency

The company has return on total asset (ROA) of (0.0119) % which means that it has lost $0.0119 on every $100 spent on assets. This is way below average. Galapagos' management efficiency ratios could be used to measure how well Galapagos manages its routine affairs as well as how well it operates its assets and liabilities.
Galapagos NV has accumulated 27.91 M in total debt with debt to equity ratio (D/E) of 0.01, which may suggest the company is not taking enough advantage from borrowing. Galapagos NV has a current ratio of 8.71, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist Galapagos until it has trouble settling it off, either with new capital or with free cash flow. So, Galapagos' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Galapagos NV sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Galapagos to invest in growth at high rates of return. When we think about Galapagos' use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Arjen MScArgen X
38
Reginald GenechtenBiocartis Group NV
57
MBA MDPharming Group NV
63
Frank ZantenKoninklijke Ahold Delhaize
53
Natalia WallenbergKoninklijke Ahold Delhaize
40
Susanne EmbletonPharming Group NV
N/A
Anurag RelanPharming Group NV
51
Jeroen WakkermanPharming Group NV
54
Chris SluysBarco NV
63
Geert CarreinBarco NV
65
David MDArgen X
71
Ruud OutersterpPharming Group NV
59
Stephen ToorPharming Group NV
52
EMBA MBAArgen X
50
Iain UrquhartBarco NV
50
Bruno GiannettiPharming Group NV
71
JohnPaul OMearaKoninklijke Ahold Delhaize
N/A
Karl GubitzArgen X
53
Kenneth WangBarco NV
51
Peter AgnefjaellKoninklijke Ahold Delhaize
48
Marc SpenleBarco NV
48
Galapagos NV, a clinical-stage biotechnology company, discovers, develops, and commercializes various small molecule medicines. Galapagos NV was founded in 1999 and is headquartered in Mechelen, Belgium. GALAPAGOS operates under Biotechnology classification in Netherlands and is traded on Amsterdam Stock Exchange. It employs 1397 people. Galapagos NV (GLPG) is traded on Euronext Amsterdam in Netherlands and employs 1,357 people.

Management Performance

Galapagos NV Leadership Team

Elected by the shareholders, the Galapagos' board of directors comprises two types of representatives: Galapagos inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Galapagos. The board's role is to monitor Galapagos' management team and ensure that shareholders' interests are well served. Galapagos' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Galapagos' outside directors are responsible for providing unbiased perspectives on the board's policies.
Elizabeth Goodwin, VP Corporate Communications & Investor Relations
Andre Hoekema, Senior Vice President - Corporate Development
John Montana, Managing Argenta
Michele MBA, Chief Board
Walid AbiSaab, Member of the Executive Committee, Chief Medical Officer
Marieke Vermeersch, Head Communication
Chantal Tasset, Head Devel
Sofie Gijsel, Head Relations
MBA MBA, COO Pres

Galapagos Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Galapagos a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Galapagos Stock Analysis

When running Galapagos' price analysis, check to measure Galapagos' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Galapagos is operating at the current time. Most of Galapagos' value examination focuses on studying past and present price action to predict the probability of Galapagos' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Galapagos' price. Additionally, you may evaluate how the addition of Galapagos to your portfolios can decrease your overall portfolio volatility.